David J Adams Selected Research

David J Adams Research Topics

Disease

70	Neoplasms (Cancer) 03/2024 - 09/2003
31	Melanoma (Melanoma, Malignant) 01/2023 - 10/2011
25	Pain (Aches) 02/2024 - 06/2004
21	Neuralgia (Stump Neuralgia) 01/2023 - 08/2006
14	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2014
12	Chronic Pain 12/2022 - 08/2004
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2010
7	Leukemia 08/2012 - 02/2002
6	Lymphoma (Lymphomas) 10/2018 - 07/2002
5	Ganglion Cysts (Ganglion) 01/2021 - 09/2003
5	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2006
4	Adenoma (Adenomas) 01/2023 - 01/2015
4	Inflammation (Inflammations) 01/2023 - 03/2008
4	Adenocarcinoma 12/2021 - 04/2012
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 02/2003
3	Parkinson Disease (Parkinson's Disease) 11/2023 - 02/2012
3	Infections 01/2023 - 12/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2018
3	Epilepsy (Aura) 01/2022 - 01/2011
3	Lung Neoplasms (Lung Cancer) 09/2020 - 01/2015
3	Hypersensitivity (Allergy) 01/2019 - 06/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 08/2013
3	Visceral Pain 01/2018 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 04/2011
3	Hyperplasia 12/2014 - 10/2006
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023 - 12/2021
2	Neuroinflammatory Diseases 01/2023 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 08/2010
2	Adenocarcinoma of Lung 11/2022 - 09/2020
2	Hyperalgesia 01/2021 - 07/2013
2	Osteoporosis 01/2021 - 10/2017
2	Carcinogenesis 11/2020 - 02/2017
2	Thrombosis (Thrombus) 01/2019 - 12/2018
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

26	Conotoxins (Conotoxin)IBA 02/2024 - 06/2004
25	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2005
17	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2024 - 01/2005
17	Peptides (Polypeptides)IBA 02/2024 - 08/2006
16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2010
16	Analgesics (Analgesic Drugs)IBA 12/2022 - 03/2008
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2014
10	Transcription Factors (Transcription Factor)IBA 01/2023 - 10/2006
9	Gemcitabine FDA Link 01/2016 - 02/2002
7	CamptothecinIBA 09/2020 - 09/2003
6	Ion Channels (Ion Channel)IBA 01/2018 - 09/2007
5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
5	LigandsIBA 11/2022 - 04/2010
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2020 - 09/2003
5	Docetaxel (Taxotere)FDA Link 04/2016 - 01/2014
4	VenomsIBA 01/2022 - 10/2008
4	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2006
4	CarcinogensIBA 11/2020 - 01/2015
4	Calcium Channels (Calcium Channel)IBA 01/2018 - 07/2013
4	DisulfidesIBA 12/2014 - 08/2006
3	Opioid Analgesics (Opioids)IBA 02/2024 - 05/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 01/2020
3	Ethanol (Ethyl Alcohol)IBA 01/2023 - 01/2017
3	CateninsIBA 11/2022 - 11/2017
3	AntigensIBA 01/2022 - 07/2016
3	SodiumIBA 01/2022 - 01/2017
3	CalciumIBA 01/2022 - 07/2013
3	IntegrinsIBA 01/2019 - 08/2015
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 04/2008
3	cyclic (arginyl- glycyl- aspartyl- phenylalanyl- lysyl)IBA 07/2017 - 08/2015
3	AcidsIBA 07/2016 - 01/2006
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2006
3	Dasatinib (BMS 354825)FDA Link 02/2014 - 04/2011
3	Sodium Channels (Sodium Channel)IBA 08/2012 - 06/2004
3	Alkylating AgentsIBA 01/2010 - 01/2006
3	Dihydrotachysterol (AT 10)IBA 02/2003 - 02/2002
2	AutoantigensIBA 01/2023 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 01/2023 - 09/2003
2	CholesterolIBA 01/2023 - 12/2012
2	trametinibIBA 11/2022 - 01/2015
2	Insulin (Novolin)FDA Link 01/2021 - 02/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 01/2021
2	EpitopesIBA 01/2021 - 10/2018
2	Mitogen Receptors (Mitogen Receptor)IBA 09/2020 - 11/2016
2	Dendrimers (Dendrons)IBA 09/2020 - 04/2016
2	CollagenIBA 01/2019 - 12/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2003
2	Small Interfering RNA (siRNA)IBA 01/2019 - 05/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 12/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2016
2	BombesinIBA 01/2019 - 01/2015
2	olaparibIBA 01/2019 - 01/2010
2	EnzymesIBA 12/2018 - 02/2015
2	ProdrugsIBA 12/2018 - 04/2011
2	AntibodiesIBA 12/2017 - 04/2005
2	Cadherins (E-Cadherin)IBA 08/2017 - 01/2010
2	Glutamic Acid (Glutamate)FDA Link 07/2017 - 09/2007
2	Deubiquitinating EnzymesIBA 01/2017 - 04/2012

Therapy/Procedure

28	Therapeutics 03/2024 - 02/2002
8	Drug Therapy (Chemotherapy) 11/2020 - 01/2005
3	Transplantation 10/2021 - 08/2010
3	Immunotherapy 12/2019 - 01/2017
2	Ligation 12/2018 - 05/2012
2	Analgesia 01/2018 - 03/2008